Literature DB >> 15133333

Our experience with nifedipine and prednisolone as expulsive therapy for ureteral stones.

A Saita1, A Bonaccorsi, F Marchese, S V Condorelli, M Motta.   

Abstract

OBJECTIVES: We evaluated the effect of nifedipine associated with prednisolone in ureteral stone passage.
MATERIAL AND METHODS: In our department we enrolled 50 patients with radiopaque ureteral stones. Stone size was 15 mm or less. The patients were divided into two groups: group I included 25 patients who received 30 mg oral treatment of slow-release nifedipine (for a maximum of 20 days) and 25 mg of prednisolone (for a maximum of 10 days) daily. Group II was made up of 25 patients who received 25 mg of prednisolone daily. On request, both groups could use non-steroidal anti-inflammatory drugs.
RESULTS: The mean expulsion time was 6 days in group I and 10 days in group II. The average stone size was 12 mm in group I and 12.8 mm in group II. Six patients suspended therapy in group I (5 erythema, 1 stomachache), and seven in group II (3 because of intolerable pain, 4 stomachache). The expulsion success rates were 68% in group I and 81% in group II.
CONCLUSIONS: For ureteral stones that do not cause an emergency situation, such as obstructive uropathy, infection or intolerable pain, we suggest expulsive medical treatment with nifedipine and prednisolone, if there are no contraindications to drug use. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133333     DOI: 10.1159/000076591

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  10 in total

1.  Effectiveness of doxazosin in the management of lower ureteral stones in male and female patients.

Authors:  Berkan Resorlu; Omer Faruk Bozkurt; Cagri Senocak; Ali Unsal
Journal:  Int Urol Nephrol       Date:  2010-11-12       Impact factor: 2.370

Review 2.  Medical expulsive therapy for distal ureteral stones.

Authors:  Vassilios Tzortzis; Charalampos Mamoulakis; Jorge Rioja; Stavros Gravas; Martin C Michel; Jean J M C H de la Rosette
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 3.  Update on medical expulsive therapy for distal ureteral stones: Beyond alpha-blockers.

Authors:  Derek Bos; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

4.  Effects of alfuzosin with methylprednisolone for spontaneous expulsion and pain control of lower ureteral stone.

Authors:  Eu Chang Hwang; In Sang Hwang; Ho Song Yu; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Soo Bang Ryu; Myung Ki Kim; Ji Wan Lu
Journal:  Urol Res       Date:  2012-05-25

Review 5.  Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic.

Authors:  A Holdgate; T Pollock
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

6.  Management of ureteral calculi and medical expulsive therapy in emergency departments.

Authors:  Stefano C M Picozzi; Carlo Marenghi; Stefano Casellato; Cristian Ricci; Maddalena Gaeta; Luca Carmignani
Journal:  J Emerg Trauma Shock       Date:  2011-01

7.  Can the Hounsfield unit predict the success of medically expulsive therapy?

Authors:  Sakip Erturhan; Omer Bayrak; Ahmet Mete; Ilker Seckiner; Gokhan Urgun; Kemal Sarica
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

8.  Role of steroidal anti-inflammatory agent prior to intracorporeal lithotripsy under local anesthesia for ureterovesical junction calculus: A prospective randomized controlled study.

Authors:  Bijit Lodh; Kaku Akoijam Singh; Rajendra Singh Sinam
Journal:  Urol Ann       Date:  2015 Apr-Jun

9.  Emergency management of ureteral stones: Recent advances.

Authors:  Luis Osorio; Estêvão Lima; Riccardo Autorino; Filinto Marcelo
Journal:  Indian J Urol       Date:  2008-10

10.  Hounsfield unit and its correlation with spontaneous expulsion of lower ureteric stone.

Authors:  Sriharsha Bokka; Amit Jain
Journal:  Ther Adv Urol       Date:  2019-12-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.